- Home
- NXTT vs TTNP Comparison
NXTT vs TTNP Comparison
Compare NXTT & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- TTNP
- Stock Information
- Founded
- NXTT 2019
- TTNP 1991
- Country
- NXTT China
- TTNP United States
- Employees
- NXTT N/A
- TTNP N/A
- Industry
- NXTT
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXTT
- TTNP Health Care
- Exchange
- NXTT NYSE
- TTNP Nasdaq
- Market Cap
- NXTT 3.5M
- TTNP 3.4M
- IPO Year
- NXTT N/A
- TTNP 1996
- Fundamental
- Price
- NXTT $0.30
- TTNP $3.96
- Analyst Decision
- NXTT
- TTNP
- Analyst Count
- NXTT 0
- TTNP 0
- Target Price
- NXTT N/A
- TTNP N/A
- AVG Volume (30 Days)
- NXTT 444.4K
- TTNP 36.1K
- Earning Date
- NXTT 05-19-2025
- TTNP 05-14-2025
- Dividend Yield
- NXTT N/A
- TTNP N/A
- EPS Growth
- NXTT N/A
- TTNP N/A
- EPS
- NXTT 3.70
- TTNP N/A
- Revenue
- NXTT $1,800,000.00
- TTNP N/A
- Revenue This Year
- NXTT N/A
- TTNP N/A
- Revenue Next Year
- NXTT N/A
- TTNP N/A
- P/E Ratio
- NXTT $0.08
- TTNP N/A
- Revenue Growth
- NXTT N/A
- TTNP N/A
- 52 Week Low
- NXTT $0.28
- TTNP $3.03
- 52 Week High
- NXTT $6.66
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- NXTT 27.46
- TTNP 47.66
- Support Level
- NXTT $0.28
- TTNP $3.48
- Resistance Level
- NXTT $0.32
- TTNP $4.47
- Average True Range (ATR)
- NXTT 0.04
- TTNP 0.33
- MACD
- NXTT 0.04
- TTNP -0.02
- Stochastic Oscillator
- NXTT 20.51
- TTNP 23.68
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.